Alta Partners

Alta Partners

This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Headquarters Location

United States, San Francisco


Alta Partners is the renowned VC, which was created in 1996. The VC's location is in North America, United States. The the headquarters of this VC is in San Francisco.

Kite Pharma, Intarcia Therapeutics, ZS Pharma are amongst the various portfolio companies of this fund. Also, a start-up has to be aged 4-5 years to expect investment from this fund. Among the most popular investment industries for the fund are Pharmaceutical, Biotechnology. However, the fund’s focus is not limited to this, since there are 19 more areas of investment. The country of its foundation and the country of the most frequent investments for the fund coincides - United States. In addition to this location, the fund participated in 8 other locations. The fund has an exact preference in the amount of founders of companies in its portfolio. If there are 5+ founders in the start-up, the probability of getting the investment is low.

The fund was established by Garrett Gruener, Guy P. Nohra, Jean Deleage. We also identified another 8 core personnel in our database.

The most common rounds for this fund are in the range of 10 - 50 millions dollars. In real terms, this VC performs 1 percentage points more exits than other funds. The fund generally invests in 7-12 deals every year. The fund's activity peaked in 2007. In addition, the fund was active in 2019. When Alta Partners invests, the average start-up valuation is 10-50 millions dollars. We recorded the biggest number of exits for this fund in 2014. Alta Partners participates, on average, in 1 percentage points more than the average amount of lead investments in other funds.

The fund usually invests in rounds together with 5-6 others. Aside from Alta Partners, start-ups are often funded by Venrock, SV Health Investors, Atlas Venture and 137 other funds. Other VCs who often invest in the same rounds are RiverVest, OrbiMed, Bay City Capital, the total number of co-investors is 184. In subsequent rounds, the fund is usually supported by New Enterprise Associates, Venrock, HBM Healthcare Investments AG, out of 134 investors from our database.

Year Founded


Fund Activity


Mail Rule [rules by which you can get an email of an interesting for you fund employee, knowing only the name and surname of this employee]

Domain name:; User name format in descending order of probability: last first_initial, first last_initial, first, first_initial last, last

Group Appearance [how often fund is operating separately from groups with shared interest]

99.0% of cases

Investments per Year [average amount of rounds in which fund participates each year]


Follow-on Index [how often fund is ready to support its portfolio startup at next rounds]

45.0% of cases

Average Multiplicator [the average ratio of the last valuation of portfolio startups to their total amount of financing raised]


Average Portfolio Company
Exit Age [the average age of portfolio startups at which they go public or become acquired]

2.3 years

Success / Strategy Similarity
Index [the matching between fund's investment strategy and its proved successes in the form of portfolio startups high valuations]

0.48 out of 1

Number of Unicorns [amount of portfolio companies, which were valuated at more then $1B]


Number of Decacorns [amount of portfolio companies, which were valuated at more then $10B]


Number of Minotaurs [amount of portfolio companies, which raised more then $1B in total]


Funds Investing in Previous

Venrock, SV Health Investors, Atlas Venture

Funds Investing Together

RiverVest, OrbiMed, Bay City Capital

If you have found a spelling error or the data isn't actual, please, notify us by selecting that text and pressing Ctrl+Enter.

Fund reviews
  • No reviews are submitted yet.
Crunchbase icon

Content report

The following text will be sent to our editors: